Eitan Frankel
Cardiovascular Disease · Philadelphia, PANPI 1659805620
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (58.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 65.1% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $21,801 and has fallen 80.5% since, to $4,256 in 2025. Among cardiovascular disease clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 242 payments — averaging $152.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$24K
- Abbott$5K
- Boston Scientific$3K
- Atricure, Inc.$892
- Biotronik Inc.$562
- Amgen$424
- plus $3K from 21 others
What the payments were for
- Grants$21,50058%
- Travel & lodging$4,29912%
- Food & beverage$9,85527%
- Education$1,2543%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 27 | $24,018 |
| Abbott | 48 | $4,663 |
| Boston Scientific | 39 | $3,004 |
| Atricure, Inc. | 15 | $892 |
| Biotronik Inc. | 9 | $562 |
| Amgen | 12 | $424 |
| AstraZeneca | 6 | $423 |
| Biosense Webster, Inc. | 7 | $422 |
| Pfizer | 22 | $406 |
| Medical Device Business Services, Inc. | 1 | $327 |
| Sanofi-aventis U.S. LLC | 3 | $247 |
| E.r. Squibb & Sons, L.L.C. | 8 | $224 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $192 |
| Impulse Dynamics (USA) Inc. | 5 | $180 |
| Novartis | 8 | $169 |
| Cardiva Medical, Inc. | 5 | $136 |
| Johnson & Johnson(2 entities) | 5 | $120 |
| Actelion Pharmaceuticals US, Inc. | 5 | $107 |
| Novo Nordisk | 1 | $104 |
| Philips North America LLC | 2 | $99 |
| Cardiovascular Systems Inc. | 2 | $41 |
| Lantheus Medical Imaging, Inc. | 2 | $35 |
| Kestra Medical Technology Services, Inc. | 1 | $30 |
| Convatec Inc. | 1 | $29 |
| Boehringer Ingelheim | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Bayer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$1,836
- ENSITE$1,178
- Micra$481
- Carto 3$477
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$413
- QUADRA ASSURA$269
- FARXIGA$238
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$208
- VersaCross Access Solution$189
- COBALT DR MRI SURESCAN$132
- AURORA EV-ICD MRI SURESCAN$128
- Repatha$118
- CAMZYOS$105
- Ozempic$104
How this compares
$36,907 in reported general payments places this provider in the 90th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Other cardiovascular disease in Philadelphia
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Dean KaralisPhiladelphia$385K
- Manavendra BakhshiPhiladelphia$250K
- Philip HainesPhiladelphia$170K
- Julio ChirinosPhiladelphia$145K
- Michael MillerPhiladelphia$133K
- Nehal MehtaPhiladelphia$129K
- Garo GaribianPhiladelphia$115K
- Norman FeinsmithPhiladelphia$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.